The Priority Review

Tag

ISTURISA

1 story

  1. Regulation

    FDA determines ISTURISA not withdrawn from sale

    The FDA has determined that ISTURISA (osilodrostat) tablets, 10 mg, was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications for osilodrostat tablets, 10 mg if all other legal and regulatory requirements are met.